Market Access strategies for a drug are that set of levers that pull and promote market access, adoption, and recognition of the drug's value. This process shifts the focus from the prescriber to a variety of stakeholders.
There are different kinds of levers than can be used to drive a successful market access strategy: from clinical and epidemiological evidence to pharmaco-economics and regulations in place.
For the proper management of a pharmaceutical product in the market, it is now essential to analyze and know its access strategies: regional approach models, hospital tenders, purchasing procedures, operational tools, and finally, stakeholders.
Market Access has an integrating role that expands over the product's life: from the first clinical trials to patent expiration. Despite this, it plays the most critical role in the clinical development phase to support the manufacturer in the reimbursability goals of the new drug.
The training sessions in Market Access cover all topics of interest: targeted notions of market access for healthcare products, positioning strategies, "payers," different scenarios, etc.
The courses are primarily aimed at those working in Market Access departments but also open to those from areas such as Marketing, Institutional Affairs and Commercial Affairs.
The courses, seminars and workshops on Market Access will enhance all the needed skills to work in this specific field.